{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:00:00Z","timestamp":1758970800655},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Yuhan Co. Ltd., Seoul, Republic of Korea."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00228-018-2502-9","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T20:39:41Z","timestamp":1529095181000},"page":"1261-1272","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjects"],"prefix":"10.1007","volume":"74","author":[{"given":"Eunwoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anhye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sojeong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Kyong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Bok","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae Mi","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seo Hyun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo-Youn","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Sang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SeungHwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,15]]},"reference":[{"issue":"12","key":"2502_CR1","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/j.1532-5415.1998.tb01543.x","volume":"46","author":"PO Katz","year":"1998","unstructured":"Katz PO (1998) Gastroesophageal reflux disease. J Am Geriatr Soc 46(12):1558\u20131565","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2502_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5056\/jnm.2014.20.1.6","volume":"20","author":"C Maradey-Romero","year":"2014","unstructured":"Maradey-Romero C, Fass R (2014) New and future drug development for gastroesophageal reflux disease. J Neurogastroenterol Motil 20(1):6\u201316","journal-title":"J Neurogastroenterol Motil"},{"issue":"3","key":"2502_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00535-016-1166-4","volume":"51","author":"K Satoh","year":"2016","unstructured":"Satoh K, Yoshino J, Akamatsu T, Itoh T, Kato M, Kamada T, Takagi A, Chiba T, Nomura S, Mizokami Y, Murakami K, Sakamoto C, Hiraishi H, Ichinose M, Uemura N, Goto H, Joh T, Miwa H, Sugano K, Shimosegawa T (2016) Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol 51(3):177\u2013194","journal-title":"J Gastroenterol"},{"issue":"9699","key":"2502_CR4","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(09)60938-7","volume":"374","author":"P Malfertheiner","year":"2009","unstructured":"Malfertheiner P, Chan FK, McColl KE (2009) Peptic ulcer disease. Lancet 374(9699):1449\u20131461","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2502_CR5","first-page":"S35","volume":"13","author":"G Sachs","year":"2001","unstructured":"Sachs G (2001) Improving on PPI-based therapy of GORD. Eur J Gastroenterol Hepatol 13(Suppl 1):S35\u2013S41","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"2502_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1046\/j.1365-2036.2000.00775.x","volume":"14","author":"PO Katz","year":"2000","unstructured":"Katz PO, Hatlebakk JG, Castell DO (2000) Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole. Aliment Pharmacol Ther 14(6):709\u2013714","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2502_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2133\/dmpk.20.153","volume":"20","author":"T Furuta","year":"2005","unstructured":"Furuta T, Shirai N, Sugimoto M, Nakamura A, Hishida A, Ishizaki T (2005) Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies. Drug Metab Pharmacokinet 20(3):153\u2013167","journal-title":"Drug Metab Pharmacokinet"},{"key":"2502_CR8","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1038\/ctg.2015.39","volume":"6","author":"RH Hunt","year":"2015","unstructured":"Hunt RH, Scarpignato C (2015) Potassium-competitive acid blockers (P-CABs): are they finally ready for prime time in acid-related disease? Clin Transl Gastroenterol 6:e119","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"2502_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pharmthera.2005.05.005","volume":"108","author":"K Andersson","year":"2005","unstructured":"Andersson K, Carlsson E (2005) Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases. Pharmacol Ther 108(3):294\u2013307","journal-title":"Pharmacol Ther"},{"issue":"4","key":"2502_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40262-015-0326-7","volume":"55","author":"H Echizen","year":"2016","unstructured":"Echizen H (2016) The first-in-class potassium-competitive acid blocker, vonoprazan fumarate: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet 55(4):409\u2013418","journal-title":"Clin Pharmacokinet"},{"key":"2502_CR11","unstructured":"Yuhan Co. Ltd. S. YH4808 Investigator Brochure (Ver 11.0). 2013. Unpublished"},{"key":"2502_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/apt.14148","volume":"46","author":"S Yi","year":"2017","unstructured":"Yi S, Lee H, Jang SB, Byun HM, Yoon SH, Cho JY, Jang IJ, Yu KS (2017) A novel K+ competitive acid blocker, YH4808, sustains inhibition of gastric acid secretion with a faster onset than esomeprazole: randomised clinical study in healthy volunteers. Aliment Pharmacol Ther 46:337\u2013346","journal-title":"Aliment Pharmacol Ther"},{"key":"2502_CR13","unstructured":"KIST (Korea Institute of Science and Technology). ADME study of YH4808 using isotope (Yuhan Co. Ltd., Seoul). 2008. Unpublished"},{"issue":"3","key":"2502_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1021\/js960085v","volume":"86","author":"WN Charman","year":"1997","unstructured":"Charman WN, Porter CJH, Mithani S, Dressman JB (1997) Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 86(3):269\u2013282","journal-title":"J Pharm Sci"},{"key":"2502_CR15","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration (FDA). Center for Drug Evaluation and Research (CDER). Guidance for industry: food-effect bioavailability and fed bioequivalence Studies 2002"},{"key":"2502_CR16","unstructured":"Rowland M, Tozer TN (2010) Clinical pharmacokinetics and pharmacodynamics: concepts and applications, 4th edn. Wolters Kluwer Health\/Lippincott William & Wilkins, Philadelphia, p 184"},{"key":"2502_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1146\/annurev.nu.16.070196.002123","volume":"16","author":"PG Welling","year":"1996","unstructured":"Welling PG (1996) Effects of food on drug absorption. Annu Rev Nutr 16:383\u2013415","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"2502_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1046\/j.1365-2125.2003.01977.x","volume":"57","author":"R Courtney","year":"2004","unstructured":"Courtney R, Wexler D, Radwanski E, Lim J, Laughlin M (2004) Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults. Br J Clin Pharmacol 57(2):218\u2013222","journal-title":"Br J Clin Pharmacol"},{"key":"2502_CR19","unstructured":"Lee PID, Amidon GL (1996) Pharmacokinetic analysis: a practical approach. CRC Press, Boca Raton, p 324"},{"issue":"3","key":"2502_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2165\/00003088-199937030-00003","volume":"37","author":"BN Singh","year":"1999","unstructured":"Singh BN (1999) Effects of food on clinical pharmacokinetics. Clin Pharmacokinet 37(3):213\u2013255","journal-title":"Clin Pharmacokinet"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2502-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2502-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2502-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T23:05:26Z","timestamp":1560553526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2502-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["2502"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2502-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,15]]},"assertion":[{"value":"4 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol was approved by the institutional review board of Seoul National University Hospital (SNUH). The studies were conducted in accordance with the Declaration of Helsinki and International Conference on Harmonization guidelines. Written informed consents were obtained prior to enrolment in the studies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors Seong Bok Jang and Hae Mi Byun are employees of Yuhan Co. Ltd. The first author (Eunwoo Kim) received a scholarship from the BK21-plus education program provided by the National Research Foundation of Korea. Sojeong Yi is currently employed by the U.S. Food and Drug Administration. Her contribution to the manuscript was based on her prior employment, and the current manuscript does not reflect any position of neither the U.S. Food and Drug Administration nor the US government. The authors have no other potential conflicts of interest to disclose regarding the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}